Cetylpyridinium chloride anti-gingivitis efficacy hinges on re-analysis of Cepacol data.
This article was originally published in The Rose Sheet
Executive Summary
CETYLPYRIDINIUM CHLORIDE EFFICACY VERSUS GINGIVITIS HINGES on a re-analysis of clinical studies using Cepacol mouthrinse that failed to show a significant reduction in gingivitis, panel member Robert Genco, DDS/PhD, suggested at an Aug. 15 meeting of the OTC Plaque Products Subcommittee of FDA's Dental Products Panel. During the meeting, the subcommittee discussed memos prepared by Genco on the safety and efficacy of three anti-plaque/gingivitis ingredients: cetylpyridinium chloride, dicalcium phosphate dihydrate and aloe vera.